biotech
Nestin: A Biomarker for Basal Epithelial Breast Cancer
Filed in archive Diagnostics, Methodologies and Instrumentation , Genomics, Proteomics and Bioinformatics by ruth on January 16, 2007
Nestin: A Biomarker for Basal Epithelial Breast Cancer
Last month, we reported on two proteins considered to be biomarkers for breast cancer metastasis onto neighboring lymph nodes. This time, a structural protein called nestinhas been linked to the incidence of basal epithelial breast tumors, a particularly deadly form of breast cancer. Since this type of breast cancer has a high rate of recurrence, testing for the nestin biomarker could lead to earlier detection and better treatment.
"Normal basal epithelial tissue produces nestin, but basal epithelial tumors produce a tremendous amount of nestin, which likely represents an abnormal expansion of the basal epithelia." DiRenzo said. "If it is indeed specific to regenerative cells, then it will make for an excellent diagnostic tool for a cancer of regenerative mammary cells."

Read more from the American Association for Cancer Research, or see the January 15 issue of the Cancer Research journal.


Permalink: Nestin: A Biomarker for Basal Epithelial Breast Cancer
Tags: cancer  diagnostics  biomarker  breast+cancer  breast  basal+epithelial  nestin+biomarker 
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/49838
img Addthis img Ask img Blinklist img del.icio.us img Digg img Fark img Facebook img Google img Lycos img Ma.gnolia Add this page to Mister Wong Mr Wong img Netscape img Netvousz img Newsvine img Reddit img StumbleUpon img Slashdot img Tailrank img Technorati img Wink img Yahoo

Vote for Nestin: A Biomarker for Basal Epithelial Breast Cancer:

  • Currently 8.67/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 8.67 out of 3 vote(s) cast.
 
Subscribe
Share It
RSSrss
See all blog subscribe options
Google google
What is RSS?
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Newsletter

TwitterFollow us on Twitter!